Predicting and preventing measles epidemics in New Zealand: Application of a mathematical model

Epidemiology and Infection

Volumn 124, Issue 2, 2000, Pages 279-287

  Roberts, M G ^a   Tobias, M I ^b  

^a AGRESEARCH   (New Zealand)

^b MINISTRY OF HEALTH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CHILD; EPIDEMIC; HUMAN; IMMUNIZATION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MEASLES; NEW ZEALAND; PREDICTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FORECASTING; HUMANS; INCIDENCE; INFANT; MEASLES; MODELS, STATISTICAL; NEW ZEALAND; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 0034089305     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899003556     Document Type: Article

References (33)

1. Ministry of Health. Immunisation handbook. 2nd edn. Wellington: Ministry of Health, 1996.
2. Dow DA, Mansoor O. New Zealand immunisation schedule history. New Zealand Med J 1996; 109: 209-12.
3. Stehr-Green P, Baker M, Belton A, et al. Immunisation coverage in New Zealand. Commun Dis New Zealand. 1992; 92 (Suppl 2): 1-22.
4. McNicholas A, Baker M. Immunisation coverage in New Zealand, 1995. New Zealand Publ Hlth Rep 1996; 3: 83-4.
5. Tobias M, Christie S, Mansoor O. Predicting the next measles epidemic. New Zealand Publ Hlth Rep 1997; 4: 1-3.
6. Mathsoft Inc. Mathcad user's guide. Cambridge MA: Mathsoft Inc., 1995.
7. Anders JF, Jacobson RM, Poland GA, Jacobsen SJ, Wollan PC, Secondary failure rates of measles vaccines: a meta-analysis of published studies. Ped Infect Dis J 1996; 15: 62-6.
8. Mathsoft Inc. Mathcad user's guide. Cambridge MA: Mathsoft Inc., 1997.
9. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press, 1991.
10. 0 in models for infectious diseases in heterogeneous populations. J Math Biol 1990; 28: 365-82.
11. Mansoor O, Blakely A, Baker M, Tobias M, Bloomfield A. A measles epidemic controlled by immunisation. New Zealand Med J 1998; 111: 467-71.
12. Agur Z, Cojocaru L, Mazor G, Anderson RM, Danon YL. Pulse mass measles vaccination across age cohorts. Proc Nat Acad Sciences USA 1993; 90: 11698-702.
13. Babad HR, Nokes DJ, Gay NJ, Miller E, Morgan-Capner P, Anderson RM. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect 1995; 114: 319-44.
14. Gay NJ, Pelletier L, Duclos P. Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy. Vaccine 1998; 16: 794-801.
15. Bolker B. Chaos and complexity in measles models: a comparative numerical study. IMA J Math Appl Med Biol 1993; 10: 83-95.
16. Grenfell BT, Bolker BM. Population dynamics of measles. In: Scott ME, Smith G, eds. Parasitic and infectious diseases. New York: Academic Press, 1994: 219-33.
17. Rhodes CJ, Anderson RM. Power laws governing epidemics in isolated populations. Nature 1996; 381: 600-2.
18. McLean AR. Control of microparasites through vaccination. In: Scott ME. Smith G, eds. Parasitic and infectious diseases. New York: Academic Press, 1994: 129-40.
19. Edelstein-Keshet L. Mathematical models in biology. New York: Random House. 1988.
20. Williams BG, Cutts FT, Dye C. Measles vaccination policy. Epidemiol Infect 1995; 115: 603-21.
21. Rosenthal SR, Clements CJ. Two-dose measles vaccination schedules. Bull WHO 1993; 71: 421-8.
22. Quadros CA, Olive JM, Alleyne GAO. Measles elimination in the Americas: Evolving strategies. J Am Med Assoc 1996; 275: 224-9.
23. Peltola H. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. New Engl J Med 1994; 331: 1397-402.
24. Peltola H. No measles in Finland. Lancet 1997; 350: 1364-5.
25. Bottiger M, Christenson B, Romanus V, Taranger J, Strandell A. Swedish experience of two-dose vaccination programme aiming at elimination of measles, mumps and rubella. BMJ 1987; 295: 1264-7.
26. Christenson B, Bottiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 1994; 12: 129-32.
27. Lévy-Bruhl D, Maccario J, Richardson S, Guérin N. Modélisation de la rougeole en France et conséquences pour l'âge d'administration de la seconde vaccination rougeole-oreillons-rubéole. Bull Epidémiol Hebd 1997; 29: 133-5.
28. Ratnam S, West R, Oates F. Immunity against measles in school-aged children: implications for measles revaccination strategies. Can J Publ Hlth 1996; 87: 407-10.
29. Ratnam S, West R, Gedag V. Wiping out measles: when to vaccinate? Can Med Assoc J 1997; 156: 979-88.
30. Forrest JM, Burgess MA, Health TC, McIntyre PB. Measles control in Australia. Commun Dis Intell 1988; 22: 33-6.
31. Statistics New Zealand. New Zealand official yearbook. Wellington: Statistics New Zealand, 1996.
32. Hethcote HW. Modelling heterogeneous mixing in infectious disease dynamics. In: Isham VS, Medley GF, eds. Models for infectious human diseases: their structure and relation to data. Cambridge: Cambridge University Press, 1996: 215-38.
33. Keeling MJ, Grenfell BT. Disease extinction and community size: modeling the presistence of measles. Science 1997; 275: 65-7.